Figure 2.The forest plot of HR for PFS in the weekly paclitaxel compared to 3-weeks paclitaxel regimen. HR: hazard ratio; PFS: progression-free survival.
Figure 2 — Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis | Aging
